Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Comparison of efficacy and safety between generic and brand formulations of ceftriaxone

  • At: 2008 FIP Congress in Basel (Switzerland)
  • Type: Poster
  • By: CHEN, Yi-Hsiu (Tzu Chi General Hospital Taipei Branch, Taipei, China Taiwan)
  • Co-author(s): Wu, Ta-Wei (Tzu Chi General Hospital Taipei Branch, TAIPEI, China Taiwan)
  • Abstract:

    After altering the manufacturer of ceftriaxone on Aug 6 2007, physicians responded that the clinical outcomes of brand formulations (denoted Ceftriaxone-B) were more superior than generic formulations (denoted Ceftriaone-G ). In our pilot study, fever reduction attained in 10/34 (29.4%) patients after using Ceftriaxone-B and in 6/36 (16.7%)..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses